| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V121329 | (1S,4R)-CC-90005 | (1S,4R)-CC-90005 is the (1S,4R)-enantiomer of CC-90005. | |
|
V123661 | 1-Oleoyl-2-linoleoyl-sn-glycerol | 91125-76-7 | 1-Oleoyl-2-linoleoyl-sn-glycerol is a diacylglycerol (DG). |
|
V77669 | [Ala113]MBP(104-118) TFA | [Ala113]MBP(104-118) TFA is a noncompetitive peptide inhibitor of protein kinase C (PKC) with IC50s in the range of 28-62 μM. | |
|
V99635 | AE 51310 | 433966-92-8 | AE 51310 is an OPN4 inhibitor. |
|
V114410 | Bisindolylmaleimide X | 131848-97-0 | Bisindolylmaleimide X (Ro 31-8425, BIM-X) is a cell-penetrating protein kinase C (PKC) inhibitor. |
|
V1525 | Go 6983 | 133053-19-7 | Go 6983 (also known as GOE-6983;Go-6983;GOE6983;Go6983) is a novel and potent pan-PKC (protein kinase C) inhibitor with potential anticancer and cardioprotective activity. |
|
V140392 | MPSD control peptide | 190711-66-1 | The MPSD control peptide is a control peptide for the MPSD peptide. |
|
V89798 | NPC-15437 dihydrochloride | 141774-20-1 | NPC-15437 dihydrochloride is a selective, penetrant and reversible protein kinase C (PKC) inhibitor with IC50 of 19 μM. |
|
V41020 | Pep2m, myristoylated (Myr-Pep2m) | 1423381-07-0 | Pep2m, myristoylated (Myr-Pep2m) is a cell-permeable (penetrable) peptide. |
|
V34806 | Phosphate acceptor peptide | 93511-94-5 | Phosphate acceptor peptide is a substrate of cAMP-dependent protein kinase (PKA). |
|
V81154 | PKC β pseudosubstrate TFA | PKC β pseudosubstrate TFA is a selective, cell-penetrable PKC inhibitor. | |
|
V142794 | PKC-IN-5 | 904458-98-6 | PKC-IN-5 is a PKC inhibitor. |
|
V142796 | PKC-IN-7 | 611234-91-4 | PKC-IN-7 is an inhibitor of PKC. |
|
V116686 | PKCε Recombinant Human Active Protein Kinase | PKCε is a subtype of the PKC protein kinase family. | |
|
V81158 | PKCθ pseudosubstrate peptide inhibitor,myristoylated | PKCθ pseudosubstrate peptide inhibitor, myristoylated is a synthetic peptide that may be utilized to study the mechanism of action of PKCθ. | |
|
V143420 | Protein Kinase C (19-31) TFA | Protein Kinase C (19-31) TFA is a protein kinase C (PKC) peptide inhibitor derived from the pseudosubstrate regulatory domain (residues 19-31) of PKCa. It is used as a protein kinase C substrate peptide to test the activity of protein kinase C. | |
|
V2682 | Ro 31-8220 | 125314-64-9 | Ro 31-8220 is a novel and potent pan-PKC inhibitor with IC50 of 5 nM, 24 nM, 14 nM, 27 nM, and 24 nM for PKC-α, PKC-βI, PKC-βII, PKC-γ, and PKC-ε, respectively, and also shows potent inhibition against MAPKAP-K1b, MSK1, GSK3β and S6K1. |
|
V1528 | Ro 31-8220 Mesylate | 138489-18-6 | Ro 31-8220 mesylate (RO31-8220;BIM IX;RO-31-8220;Bisindolylmaleimide IX;RO-318220), the mesylate salt of Ro 31-8220, is a novel and potent pan-PKC inhibitor with potential anticancer activity. |
|
V103082 | SBI-0087702 | 864431-36-7 | SBI-0087702 promotes the cytoplasmic localization of ATF2 in melanoma cells. |
|
V1523 | Sotrastaurin (AEB071) | 425637-18-9 | Sotrastaurin (also known as AEB-071; AEB071; AEB 071) is an orally bioavailable, potent and selective pan-PKC inhibitor with potential antineoplastic activity. |